20.01.2016 • News

J&J to cut 3,000 jobs in Medical Devices

US healthcare giant Johnson & Johnson has announced it will eliminate about 3,000 jobs in its medical devices division, or about 4-6% of the unit’s global workforce. The move is expected to generate annual cost savings of $800 million to $1 billion and allow the company to focus on more innovative products. Most of the savings are expected by the end of 2018, including about $200 million in 2016.

The job cuts will affect J&J's orthopedics, surgery and cardiovascular operations, but the company told US news agencies it had no immediate plans to eliminate specific products. The consumer medical devices, vision care and diabetes care will not be affected, Sales of J&J's underperforming medical device division fell by around 10% to nearly $19 billion in the first three quarters of 2015, The company will report fourth quarter results next week.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.